ViroGates A/S (CPH:VIRO)
Denmark flag Denmark · Delayed Price · Currency is DKK
10.55
-0.90 (-7.86%)
Jul 25, 2025, 3:46 PM CET

ViroGates Company Description

ViroGates A/S, an in vitro diagnostics company, develops and sells blood tests for measuring chronic inflammation for the healthcare sector.

It offers suPARnostic, a proprietary biomarker used in hospital clinics to guide and inform individuals of their health state, and in hospitals to support clinical decisions and identify high-risk patients, as well as used for a range of acute and chronic health issues, such as cardiovascular disease, type 2 diabetes, and cancer.

The company’s product includes suPARnostic TurbiLatex, a latex particle-enhanced turbidimetric immunoassay that quantitatively determines the soluble urokinase plasminogen activator receptor (suPAR) level in human K2-EDTA- or lithium heparin plasma samples; suPARnostic ELISA that provides fully quantitative results; and suPARnostic Quick Triage kit for use in the point of care situation for early warning and patient triaging that allows clinicians and nurses to obtain a fast patient prognosis for patient disease severity, progression, and outcome.

ViroGates A/S was founded in 2000 and is headquartered in Birkerød, Denmark.

ViroGates A/S
ViroGates logo
CountryDenmark
Founded2000
IndustryMedical Devices
SectorHealthcare
Employees10
CEOJakob Knudsen

Contact Details

Address:
Banevaenget 13
Birkerød, 3460
Denmark
Phone45 21 13 13 36
Websitevirogates.com

Stock Details

Ticker SymbolVIRO
ExchangeCopenhagen Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyDKK
ISIN NumberDK0061030574
SIC Code3845

Key Executives

NamePosition
Jakob KnudsenChief Executive Officer
Dr. Jesper Eugen-OlsenCo-Founder and Chief Scientific Officer
Josephine Baum JorgensenChief Financial Officer
May Britt DyvelkovVice President of Accounting
Thomas KrarupVice President of Global Sales and Marketing